Funding for this research was provided by:
European Commission (779312)
Università Commerciale Luigi Bocconi
Article History
Received: 25 April 2022
Accepted: 11 October 2022
First Online: 5 November 2022
Declarations
:
: MM has no conflict of interest. EN reports personal fees from Dolon Ltd outside the submitted work and has no conflict of interest. MD has conducted research and consulting on rare diseases outside the submitted work.